top of page
2000_W1_Carbofix.png

Ancora.ai AG

Ancora.ai accelerates medical innovation. Clinical research is an ineffective, $47B industry, where 80% of trials are delayed due to recruitment challenges, meaning lifesaving drugs are slower to market. Ancora.ai is an AI-powered platform that seamlessly connects key research stakeholders. Using Ancora.ai, anyone can identify relevant trials in minutes. Ancora.ai is used in 100+ countries, has received multiple awards and press coverage, including by Forbes, WIREDHealth and Business Insider.

Vertical:
Health & Nutrition
Year:
2021
Ranking:
Finalist 2021
bottom of page